Fundamentos de 4OGN
visão geral do detalhamento das receitas de ORGANON & CO.
A receita de ORGANON & CO. no último ano foi de 6.19 B EUR, a maior parte da qual — 2.75 B EUR — veio da sua fonte de melhor performance no momento, Other, que no ano anterior gerou 2.53 B EUR. A maior contribuição para o valor da receita foi feito por Europe and Canada — que ano anterior gerou para ORGANON & CO. 1.70 B EUR, e no ano anterior a esse — 1.52 B EUR.
Por fonte
2017
2018
2019
2020
2021
2022
2023
2024
0,00
1,70 B
3,40 B
5,10 B
6,80 B
Women's Health - Nexplanon/Implanon NXT
Cardiovascular - Atozet
Respiratory - Singulair
Other - Other
Cardiovascular - Zetia
Other Non-opioid Pain, Bone and Dermatology
Respiratory - Nasonex
Biosimilars - Renflexis
Non-opioid Pain, Bone and Dermatology - Arcoxia
Other
Cardiovascular - Cozaar/Hyzaar
Women's Health - Follistim AQ
Other Women's Health
Merck Retained - Supply to Merck Affiliates
Merck Retained - Keytruda
Other Merck Retained
Women's Health - NuvaRing
Cardiovascular - Vytorin
Respiratory - Dulera
Moeda: EUR
2017
2018
2019
2020
2021
2022
2023
2024
Women's Health - Nexplanon/Implanon NXT
555,76 M
676,56 M
779,26 M
751,99 M
930,24 M
Cardiovascular - Atozet
370,23 M
402,94 M
427,00 M
470,22 M
456,91 M
Respiratory - Singulair
377,59 M
363,35 M
384,02 M
366,03 M
346,79 M
Other - Other
—
196,19 M
304,60 M
289,02 M
316,84 M
Cardiovascular - Zetia
393,94 M
332,56 M
333,57 M
277,24 M
306,22 M
Other Non-opioid Pain, Bone and Dermatology
—
—
255,08 M
249,15 M
284,96 M
Respiratory - Nasonex
—
—
222,38 M
—
266,61 M
Biosimilars - Renflexis
—
—
—
251,87 M
264,68 M
Non-opioid Pain, Bone and Dermatology - Arcoxia
210,86 M
214,67 M
225,18 M
—
260,81 M
Other
3,30 B
2,63 B
2,54 B
2,53 B
2,75 B
Cardiovascular - Cozaar/Hyzaar
315,48 M
314,08 M
301,80 M
254,59 M
—
Women's Health - Follistim AQ
—
208,51 M
—
237,37 M
—
Other Women's Health
—
205,87 M
—
—
—
Merck Retained - Supply to Merck Affiliates
442,97 M
—
—
—
—
Merck Retained - Keytruda
432,35 M
—
—
—
—
Other Merck Retained
216,58 M
—
—
—
—
Women's Health - NuvaRing
—
—
—
—
—
Cardiovascular - Vytorin
—
—
—
—
—
Respiratory - Dulera
—
—
—
—
—
Por país
2017
2018
2019
2020
2021
2022
2023
2024
0,00
1,70 B
3,40 B
5,10 B
6,80 B
Europe and Canada
United States
Asia Pacific and Japan
Latin America, Middle East, Russia and Africa
China
Global
Europe, Middle East and Africa
Latin America
Other Asia Pacific
Japan
Canada
Moeda: EUR
2017
2018
2019
2020
2021
2022
2023
2024
Europe and Canada
—
1,53 B
1,52 B
1,52 B
1,70 B
United States
1,15 B
1,22 B
1,34 B
1,34 B
1,52 B
Asia Pacific and Japan
—
1,03 B
1,07 B
1,02 B
1,01 B
Latin America, Middle East, Russia and Africa
—
739,90 M
836,25 M
874,30 M
998,82 M
China
713,50 M
820,84 M
856,81 M
782,79 M
818,18 M
Global
5,72 M
204,99 M
141,09 M
139,53 M
132,34 M
Europe, Middle East and Africa
2,53 B
—
—
—
—
Latin America
755,18 M
—
—
—
—
Other Asia Pacific
693,07 M
—
—
—
—
Japan
625,23 M
—
—
—
—
Canada
151,20 M
—
—
—
—